Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 46
Filter
1.
J Fr Ophtalmol ; 47(7): 104190, 2024 Apr 25.
Article in French | MEDLINE | ID: mdl-38669863

ABSTRACT

BACKGROUND: Removal of orbital foreign bodies is a surgical challenge. The purpose of this study is to report our experience in the removal of orbital foreign bodies and to evaluate the usefulness of various technological aids in their removal. MATERIALS AND METHODS: We conducted a single-center retrospective study at Nice University Hospital (France) from January 2017 to December 2023. All patients undergoing surgery for an orbital foreign body during the study period were included. Data recorded included the nature of the orbital foreign body, its size, location, surgical route, outcome (success, partial success, failure), and technological aids used (intraoperative navigation, intraoperative imaging scope, orbital magnet). Concurrently, we designed a dedicated orbital magnet, which was tested in the anatomy laboratory and in two of our patients. RESULTS: Six patients, all young men, were included during the study period. Removal was successful, partially successful, or unsuccessful in one-third of cases, respectively. Failure was associated with orbital foreign bodies located in the intraconal or posterior orbital space. Preoperatively, the use of a "low-artifact" scanner allowed us to better determine the exact size and shape of the orbital foreign body. Intraoperative navigation was not accurate enough, due to the mobility of the orbital bodies within the orbital fat. In our experience, intraoperative scope imaging was more accurate. The use of a dedicated orbital magnet was successfully tested in the anatomy laboratory and allowed the removal of a small orbital foreign body in one of our patients. Intraoperative surgical videos are provided. CONCLUSION: Vegetal orbital foreign bodies must be systematically removed. Removal of non-vegetal orbital foreign bodies should be considered on a case-by-case basis based on their size, best assessed using a "low artifact" scanner, their location, and their intrinsic ferromagnetism. Intraoperative navigation does not appear useful, while intraoperative scope imaging does. A dedicated orbital magnet might be helpful in removing ferromagnetic orbital foreign bodies. However, an orbital magnet may be ineffective in removing intraorbital bullets, since they are made primarily of an alloy of copper and lead.

7.
J Fr Ophtalmol ; 45(4): 413-422, 2022 Apr.
Article in French | MEDLINE | ID: mdl-35109988

ABSTRACT

OBJECTIVE: To evaluate diagnostic and therapeutic practices and then establish a consensus on the management of ocular toxoplasmosis in France through a Delphi study. MATERIALS AND METHODS: Twenty-three French experts in ocular toxoplasmosis were invited to respond to a modified Delphi study conducted online, in the form of two questionnaires, in an attempt to establish a consensus on the diagnosis and management of this pathology. The threshold for identical responses to reach consensus was set at 70 %. RESULTS: The responses of 19 experts out of the 23 selected were obtained on the first questionnaire and 16 experts on the second. The main elements agreed upon by the experts were to treat patients with a decrease in visual acuity or an infectious focus within the posterior pole, to treat peripheral lesions only in the presence of significant inflammation, the prescription of first-line treatment with pyrimethamine-azithromycin, the use of corticosteroid therapy after a period of 24 to 48hours, the prophylaxis of frequent recurrences (more than 2 episodes per year) with trimethoprim-sulfamethoxazole as well as the implementation of prophylactic treatment of recurrences in immunocompromised patients. On the other hand, no consensus emerged with regard to the examinations to be carried out for the etiological diagnosis (anterior chamber paracentesis, fluorescein angiography, serology, etc.), second-line treatment (in the case of failure of first-line treatment), or treatment of peripheral foci. CONCLUSION: This study lays the foundations for possible randomized scientific studies to be conducted to clarify the management of ocular toxoplasmosis, on the one hand to confirm consensual clinical practices and on the other hand to guide practices for which no formal consensus has been demonstrated.


Subject(s)
Toxoplasmosis, Ocular , Azithromycin/therapeutic use , Delphi Technique , Humans , Recurrence , Toxoplasmosis, Ocular/diagnosis , Toxoplasmosis, Ocular/epidemiology , Toxoplasmosis, Ocular/therapy , Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use
8.
J Fr Ophtalmol ; 45(3): 277-287, 2022 Mar.
Article in French | MEDLINE | ID: mdl-35078645

ABSTRACT

Dupilumab is a recombinant monoclonal IgG4 type antibody which inhibits IL4 and IL13 signaling. It is indicated in moderate to severe atopic dermatitis (AD) in adults and adolescents over 12 years of age. Its side effects include conjunctivitis and blepharoconjunctivitis, affecting between 4.7% and 28% of patients depending on the study. The incidence of conjunctivitis in patients treated with dupilumab for AD appears to be higher than placebo in clinical studies. This increase was not observed in patients treated with dupilumab for asthma or sinonasal polyposis. The risk factors for conjunctivitis in patients with AD are disease severity, pre-existence of conjunctivitis and low concentrations of dupilumab, but the pathophysiology of this disease is poorly understood. A literature search carried out in April and May 2020 showed an increase in the number of publications on the subject, but there are currently no official joint dermatologist-ophthalmologist recommendations for prevention and management. The objective of this article is to provide an overview of the status of this subject, to address the main questions raised by this type of conjunctivitis and to suggest a course of action for starting and continuing treatment with dupilumab in patients with AD, according to the recommendations of the French Ophthalmologist/Dermatologist group CEDRE.


Subject(s)
Conjunctivitis , Dermatitis, Atopic , Eczema , Adolescent , Adult , Antibodies, Monoclonal, Humanized , Conjunctivitis/chemically induced , Conjunctivitis/drug therapy , Conjunctivitis/epidemiology , Dermatitis, Atopic/drug therapy , Dermatitis, Atopic/epidemiology , Eczema/drug therapy , Humans , Severity of Illness Index , Treatment Outcome
9.
J Fr Ophtalmol ; 43(4): 341-361, 2020 Apr.
Article in French | MEDLINE | ID: mdl-31818505

ABSTRACT

Controlling long-term inflammation during non-infectious intermediate, posterior or panuveitis while limiting side effects remains challenging. There is no standardized pre-therapeutic evaluation providing diagnostic certainty, but some simple tests allow us to identifiy the main etiologies. The ophthalmologist identifies the type of uveitis, and the internist completes the investigations according to the ophthalmologist's findings. Fundus photographs, optical coherence tomography, and fluorescein and indocyanine green angiography should be considered during diagnosis and follow-up. Ocular complications of uveitis are numerous. They require close monitoring and specific medical and sometimes surgical management. The growing number of available drugs makes it possible to optimize the management of these conditions with varied etiologies and presentations. Currently, systemic corticosteroids remain the mainstay of therapy, and other alternatives are considered in the case of poor tolerance, steroid resistance or dependence. The choice of a systemic, periocular or intravitreal treatment depends on several factors: chronicity or recurrence of uveitis, duration, bilaterality, association with a systemic inflammatory disease, the presence of contraindications to certain treatments, and also socioeconomic constraints. It is of the utmost importance to find the best compromise allowing tight control of ocular inflammation by means of adapted systemic and/or local treatment while avoiding the main complications.


Subject(s)
Panuveitis/therapy , Uveitis, Intermediate/therapy , Uveitis, Posterior/therapy , Glucocorticoids/therapeutic use , Humans , Immunosuppressive Agents/therapeutic use , Panuveitis/diagnosis , Panuveitis/epidemiology , Tomography, Optical Coherence , Uveitis, Intermediate/diagnosis , Uveitis, Intermediate/epidemiology , Uveitis, Posterior/diagnosis , Uveitis, Posterior/epidemiology , Vision Disorders/diagnosis , Vision Disorders/drug therapy , Vision Disorders/epidemiology
11.
J Fr Ophtalmol ; 36(7): 567-74, 2013 Sep.
Article in French | MEDLINE | ID: mdl-23684995

ABSTRACT

Acute myositis is the second most common component of non-specific orbital inflammation. We will describe its clinical features and natural history. This is a retrospective study of 10 cases. The diagnosis of acute myositis was based on clinical and imaging criteria. Our study includes five men and five women. The average age was 35.8 years (17-59 years). Clinical symptoms were: pain increased on eye movement (10/10), diplopia (4/10), proptosis (6/10), visual loss (3/10), lid edema (6/10), conjunctival hyperemia (7/10), anterior scleritis (2/10), episcleritis (2/10), chemosis (4/10), upper lid retraction (1/10), limitation of eye movement (3/10), fundus abnormalities (2/10). Imaging showed thickening of one or more extraocular muscles (10/10). Recovery was complete with anti-inflammatory therapy in six patients. Three patients experienced recurrence, and one patient had a clinical rebound upon tapering the treatment. Acute myositis can be defined by pain on eye movement, signs of inflammation, and extraocular muscle thickening on imaging. If the clinical presentation is typical, histopathological analysis can be deferred but remains necessary in cases of poor response to treatment, chronic duration or suspicion of tumor infiltration. The diagnosis of acute myositis may be suspected in the presence of consistent, well-defined clinical signs. Contiguous inflammation is often associated. Treatment is based on steroids or non-steroidal treatment anti-inflammatory therapy, administered alone or consecutively. Recurrences are frequent but do not alter the final prognosis.


Subject(s)
Orbital Diseases/therapy , Orbital Myositis/diagnosis , Orbital Myositis/therapy , Acute Disease , Adolescent , Adult , Female , Humans , Male , Middle Aged , Orbital Diseases/complications , Orbital Diseases/diagnosis , Orbital Myositis/complications , Recurrence , Retrospective Studies , Young Adult
12.
J Fr Ophtalmol ; 36(3): 236-41, 2013 Mar.
Article in French | MEDLINE | ID: mdl-22986026

ABSTRACT

INTRODUCTION: Airsoft guns have become more common in France since the Decree of March 24, 1999, allowing people over 18 years of age to use weapons with an energy level below 2J. The present study aimed to assess the relationship between the context of Airsoft gun pellet related ocular injuries and their clinical consequences, in order to determine an effective prevention strategy. METHODS: A retrospective analysis of ocular injuries due to Airsoft gun pellets was conducted in two hospitals in northern France between September 2009 and August 2010. RESULTS: Six patients with a mean age of 12.6 ± 3.2 years were included. The most frequent injuries were corneal abrasion, hyphema and iris trauma. Functional sequelae were observed in 50% of cases and surgical intervention was necessary in one third of cases. A direct shot had occurred in all cases. In 83% of cases, the accident took place while playing in or around the house. In one out of every two cases, the gun had been won at a booth in a fair or had been purchased in a big-box store and in no cases did the patients own safety glasses. CONCLUSION: The strong appeal of Airsoft guns to minors leads us to propose several practical measures to help protect them, with the main one being to forbid selling these guns outside of specialized stores.


Subject(s)
Eye Injuries/epidemiology , Firearms , Wounds, Gunshot/epidemiology , Adolescent , Athletic Injuries/epidemiology , Athletic Injuries/etiology , Athletic Injuries/prevention & control , Child , Contact Lenses/statistics & numerical data , Corneal Injuries , Equipment Design , Eye Foreign Bodies/etiology , Eye Injuries/etiology , Eye Injuries/prevention & control , Eye Protective Devices/statistics & numerical data , Eyeglasses/statistics & numerical data , Female , Firearms/legislation & jurisprudence , Forensic Ballistics/statistics & numerical data , France/epidemiology , Humans , Iris/injuries , Male , Plastics , Retrospective Studies , Vitreous Hemorrhage/epidemiology , Vitreous Hemorrhage/etiology , Wounds, Gunshot/etiology , Wounds, Gunshot/prevention & control
13.
J Fr Ophtalmol ; 34(2): 122-6, 2011 Feb.
Article in French | MEDLINE | ID: mdl-21236513

ABSTRACT

Treatment of anterior uveitis should be etiological when a cause has been identified and provided for any symptomatic case, using topical corticosteroids and mydriatics/cycloplegics. Periocular and systemic agents are then used in certified cases that prove to be refractory to first-line therapy. If anterior uveitis is still rebellious to treatment, the physician should evaluate the accuracy of the present therapy in case of an unsuspected cause of uveitis, or a particularly severe or chronic intraocular inflammation.


Subject(s)
Adrenal Cortex Hormones/therapeutic use , Mydriatics/therapeutic use , Uveitis, Anterior/drug therapy , Uveitis, Anterior/etiology , Adrenal Cortex Hormones/adverse effects , Adult , Child , Chronic Disease , Diagnosis, Differential , Humans , Immunosuppressive Agents/adverse effects , Immunosuppressive Agents/therapeutic use , Iridocorneal Endothelial Syndrome/diagnosis , Methotrexate/adverse effects , Methotrexate/therapeutic use , Mydriatics/adverse effects , Ophthalmic Solutions , Recurrence , Tumor Necrosis Factor-alpha/antagonists & inhibitors
14.
J Fr Ophtalmol ; 32(4): 280-3, 2009 Apr.
Article in French | MEDLINE | ID: mdl-19769860

ABSTRACT

We report the case of an 86-year-old man with unilateral panuveitis concurrent with an infectious retinal focus. The diagnosis of endogenous endophthalmitis with subretinal abscess was suggested. The biology workup and CT scan showed a renal abscess. This was caused by Klebsiella pneumoniae, which was confirmed by analysis of abscess aspiration and vitrectomy samples. This paper underscores the importance of etiological assessment in infectious panuveitis and the consequences on visual outcome.


Subject(s)
Abdominal Abscess/complications , Endophthalmitis/microbiology , Kidney Diseases/complications , Klebsiella Infections/etiology , Klebsiella pneumoniae , Aged, 80 and over , Humans , Male
15.
J Fr Ophtalmol ; 32(5): 350.e1-4, 2009 May.
Article in French | MEDLINE | ID: mdl-19769873

ABSTRACT

INTRODUCTION: Dirofilariasis is a disease rarely seen in humans, occurring commonly in noncarnivorous mammals. The microfilariae are transmitted by a mosquito vector. Ocular dirofilariasis is rarely described in the ophthalmic literature. CASE REPORT: An 81-year-old woman living in the north of France had a history of sudden pain and swelling of the left orbit. On slit lamp examination, a white worm was seen under the superior bulbar conjunctiva. Excision of the subconjunctival worm was adequate treatment and was important for parasite identification. DISCUSSION: Dirofilariasis is broad-based and is more common in Italy. Cases in France are found in the south. Ocular symptoms are frequently subconjunctival, but many cases of orbital involvement are found. Treatment is only surgical; systemic medication is not necessary. CONCLUSION: Ocular dirofilariasis is exceptional. Case reports in ophthalmic literature are rare. This parasite infection is probably underdiagnosed.


Subject(s)
Conjunctival Diseases/parasitology , Dirofilariasis , Eye Infections, Parasitic , Aged, 80 and over , Dirofilariasis/diagnosis , Eye Infections, Parasitic/diagnosis , Female , Humans
16.
Rev Med Interne ; 28(1): 33-7, 2007 Jan.
Article in French | MEDLINE | ID: mdl-17166634

ABSTRACT

INTRODUCTION: Almost 50% of patients with Wegener's granulomatosis (WG) develop ocular features, leading to visual loss in 8%. However, central retinal artery occlusion (CRAO) has exceptionally been reported. EXEGESIS: We report 2 patients with CRAO and WG according to ACR classification criteria. A literature search indicates that CRAO with WG has only been reported in 15 patients. We analyse the 17 cases to discuss systemic manifestations, ocular prognosis and treatment. CONCLUSION: CRAO is a rare manifestation of WG. Nevertheless, CRAO seems to be associated with vasculitic type of WG. So, a prompt diagnosis could lead to early aggressive regimen to improve visual and general prognosis.


Subject(s)
Granulomatosis with Polyangiitis/complications , Retinal Artery Occlusion/etiology , Aged , Female , Humans , Male , Middle Aged
17.
J Fr Ophtalmol ; 28(5): 490-6, 2005 May.
Article in French | MEDLINE | ID: mdl-15976715

ABSTRACT

Galactosemia is an inherited metabolic disorder due to a defect in one of the three enzymes required to fully metabolize the galactose in glucose: the galactose 1-phosphate uridyltransferase. Because this enzyme is present in the normal foetal liver since the tenth week of gestation, its defect cause congenital abnormality due to galactose accumulation, when the mother had taken milk during the pregnancy. It is mainly a liver pathology whereas the foetal cataract is rare. This latter is usually considered as the sole ophthalmic consequence of this disorder but exceptional ocular haemorrhages have also been described. We report the case of a neonate with galactosemia free from foetal cataract but presenting an unilateral vitreous haemorrhage. Retinal anomalies seen after vitrectomy are probably the source of the vitreous blood favoured by the coagulopathy associated with the neonatal disease. The causes of infant vitreous haemorrhages are often debated and their complications, especially severe amblyopia, require vitrectomy within the month following their discovery. In galactosemia, vitreous haemorrhage can be prevented by an early diagnosis and an appropriate treatment of the liver pathology.


Subject(s)
Galactosemias/diagnosis , Vitreous Hemorrhage/etiology , Humans , Infant, Newborn , Liver/embryology , Liver/enzymology , Male , UDPglucose-Hexose-1-Phosphate Uridylyltransferase/deficiency , Vitrectomy , Vitreous Hemorrhage/surgery
18.
J Fr Ophtalmol ; 27(9 Pt 1): 1017-24, 2004 Nov.
Article in French | MEDLINE | ID: mdl-15557864

ABSTRACT

PURPOSE: The aim of this study is to investigate the importance of occlusion therapy for amblyopia in patients with partial unilateral congenital cataracts that were discovered after 24 months of age. MATERIAL AND METHODS: A retrospective study was conducted on 11 patients, each of whom underwent a clinical examination including a cycloplegic refraction with atropine. The average age when the cataract was diagnosed was 35 months. The average distance visual acuity was 6/78 and the average near visual acuity was 35/175. Occlusion therapy using adhesive patches was started after refractive error correction. In two cases, observance was mediocre. RESULTS: Ametropia was found in every patient, with anisometropia in nine patients (alpha < 0.02). This anisometropia included an astigmatism that was always greater on the side with the cataract (alpha < 0.001), averaging 2.7 diopters. After occlusion therapy for amblyopia, the average visual acuity significantly improved to 6/22 in distance vision (alpha < 0.02) and 35/45 in near vision (alpha < 0.01). The average follow-up period was 28 months (5-60 months). CONCLUSION: Amblyopia is related to lens opacities as well as frequently associated anisometropia. Functional improvement is greater in near vision than in distance vision. With occlusion therapy for amblyopia, accommodation is preserved. This factor is of utmost importance as near vision is preferential in young children. This study provides an opportunity to recall the importance of refraction and occlusion therapy for amblyopia, which must be systematically attempted in cases of partial unilateral congenital cataracts before considering a surgical procedure.


Subject(s)
Amblyopia/etiology , Amblyopia/therapy , Cataract/congenital , Cataract/complications , Cataract/diagnosis , Child, Preschool , Humans , Infant , Retrospective Studies , Time Factors
19.
J Fr Ophtalmol ; 27(9 Pt 1): 1039-42, 2004 Nov.
Article in French | MEDLINE | ID: mdl-15557867

ABSTRACT

We report a 42-year-old woman with a hemangiopericytoma tumor located in nasal fossae, revealed by acute dacryocystitis. Clinical rhinoscopic examination and orbitofacial tomodensitometry showed tumefaction of the lacrimal sac and nasolacrimal duct. We removed the tumor by endonasal surgery. The anatomopathology examination confirmed the diagnosis of hemangiopericytoma. The internal canthus area and the maxillary sinus roof were treated with complementary irradiation.


Subject(s)
Dacryocystitis/etiology , Hemangiopericytoma/complications , Nasal Cavity , Nose Neoplasms/complications , Acute Disease , Adult , Female , Hemangiopericytoma/diagnosis , Humans , Nose Neoplasms/diagnosis
20.
J Fr Ophtalmol ; 27(2): 184-7, 2004 Feb.
Article in French | MEDLINE | ID: mdl-15029050

ABSTRACT

Granulocytic sarcoma is a rare orbital complication of acute leukemia. It concerns primarily children under 10 years of age suffering from primitive acute myeloid leukemia. As this type of symptom can sometimes affect the elderly during the acute phase of myelodysplastic syndrome, it raises a problem with diagnosis and consequently with therapeutic treatments. We report the case of a 77-year-old female patient who had acute inflammatory proptosis during regressive right ethmoiditis. The diagnosis was reached by computed tomography showing an extraconical intraorbital tumor sprouting from the sinus, and by clinical examination and confirmed by the hematological investigation. Acute proptosis developing in an acute myeloblastic leukemia context heavily swayed diagnosis towards orbital granulocytic sarcoma. Chemotherapy by cytarabine and hydroxycarbamide associated with intravenous corticoid therapy resulted in complete disappearance of the proptosis within 10 days. This case report is a reminder of this peculiar sign of tumoral syndrome in acute myeloid leukemia. We also discuss different diagnostic methods and various therapeutic approaches, and analyze the disease course and patient follow-up.


Subject(s)
Myelodysplastic Syndromes/diagnosis , Orbital Neoplasms/etiology , Sarcoma, Myeloid/etiology , Acute Disease , Aged , Female , Humans , Myelodysplastic Syndromes/complications
SELECTION OF CITATIONS
SEARCH DETAIL
...